Translational Genomics Research Institute: Circulating Tumor DNA Guides Chemotherapy Use in Stage II Colon Cancer
June 04, 2022
June 04, 2022
PHOENIX, Arizona, June 4 (TNSjou) -- The Translational Genomics Research Institute issued the following news release:
* * *
Researchers from TGen, a part of City of Hope, contribute to study supporting value of ctDNA in assessing treatment options
* * *
Tumor DNA circulating in the bloodstream can help clinicians decide whether chemotherapy is right for their patients who have undergone surgery for stage II colon cancer, according to a breakthr . . .
* * *
Researchers from TGen, a part of City of Hope, contribute to study supporting value of ctDNA in assessing treatment options
* * *
Tumor DNA circulating in the bloodstream can help clinicians decide whether chemotherapy is right for their patients who have undergone surgery for stage II colon cancer, according to a breakthr . . .